Talk:Daiichi Sankyo

From Wikipedia, the free encyclopedia
Jump to: navigation, search
WikiProject Companies (Rated Start-class)
WikiProject icon This article is within the scope of WikiProject Companies, a collaborative effort to improve the coverage of companies on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.
Start-Class article Start  This article has been rated as Start-Class on the project's quality scale.
 ???  This article has not yet received a rating on the project's importance scale.
 
WikiProject Business (Rated Start-class)
WikiProject icon This article is within the scope of WikiProject Business, a collaborative effort to improve the coverage of business articles on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.
Start-Class article Start  This article has been rated as Start-Class on the project's quality scale.
 ???  This article has not yet received a rating on the project's importance scale.
 

Removed the erranous food/beverage analogy. It doesn't belong in an encyclopedia entry for this company Brettgo1 12:51, 22 October 2006 (UTC)

WikiProject class rating[edit]

This article was automatically assessed because at least one WikiProject had rated the article as stub, and the rating on other projects was brought up to Stub class. BetacommandBot 14:54, 9 November 2007 (UTC)

Combination Therapies missing from Product list[edit]

Products like Azor and Trivasc (CS-8635) (still pending FDA approval in US) should be be included in the product line up. Perhaps as a sub-bullet of Benicar, as they are derivatives of Benicar.

Also recently, DSI launched in Japan (4/16) Rezaltas (I think this is Trivasc from the description, not sure though). Can someone more knowledgeable confirm this? http://www.daiichisankyo.com/news/2010_04_16_242e2.pdf

Misosoup7 (talk) 21:18, 6 May 2010 (UTC)